By Fernanda Ruiz, NOVA Research Company Alzheimer’s Disease (AD) is a devastating disease that affects more than 6 million Americans, a number that is projected to increase considerably in the near future. Scientists looking for the causes of AD use different approaches, including genomic studies like genome-wide association studies (GWAS), that detect associations between genetic […]
PNGC would like to congratulate Edward Lee, MD, Ph.D., Associate Professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania and a practicing neuropathologist in the Division of Neuropathology on earning tenure! Dr. Lee has been at Penn since 1997, where he did his MD/Ph.D. from 1997 to […]
By Fernanda Ruiz, NOVA Research Company Alzheimer’s disease (AD) is a degenerative disease that likely is caused by a combination of environmental, lifestyle, and genetic factors, and increasing age. Alzheimer’s Disease Sequencing Project (ADSP) researchers are focused on gaining further insights into the genetic component of this disease, including the role of structural variants (SVs), […]
PNGC is excited to announce that the Genome Center for Alzheimer’s Disease (GCAD) has received a 5-year grant renewal totaling $20 million to continue their work. GCAD, a collaborative research center between Penn, Boston University, Case Western Reserve University, Columbia University, the University of Miami, and the University of Indiana, aims to identify AD-related genes […]
The Collaborative for Alzheimer’s Disease Research (CADRE) and the Alzheimer’s Disease Genetics Consortium (ADGC) are creating a new multi-institutional seminar series to support next generation researchers in Alzheimer’s disease process, diagnosis and care by encouraging collaboration within the AD research community. The new Trans-Institutional Seminar Series will highlight up-and-coming junior investigators to help strengthen their […]
By Kathy Sedgwick, NOVA Research Company Dr. Alessandra Chesi joined the University of Pennsylvania faculty as an Assistant Professor of Pathology and Laboratory Medicine in July 2020. Her work at Penn focuses on the application of transformative technologies as well as functional genomics and systems biology approaches toward gaining insight into the regulation and identity […]
The NIH will host their 2021 Alzheimer’s Research Summit April 19-22. This virtual summit will convene leading AD scientists, innovators, and public health advocates to showcase progress in Alzheimer’s disease research and ideas for supporting the goal of precision medicine for Alzheimer’s treatment and prevention. On Tuesday, April 20, Drs Li-San Wang (Penn) and Timothy […]
The National Institute on Aging (NIA) recently announced a new resource that will help teach and assist those whose lives are affected by Alzheimer’s disease and related dementias. Alzheimers.gov is a website that serves as the federal government portal for dementia information and resources. To create Alzheimers.gov, the NIA worked with individuals living with dementia, […]
Join leading scientists, patient advocacy groups, and government members April 19-22 for the 2021 NIH Alzheimer’s Research Summit to showcase Alzheimer’s disease research developments. The virtual summit’s agenda and registration are now available and can be accessed via the NIA Summit website.
University of Pennsylvania senior and PNGC undergraduate researcher Lauren Kleidermacher was awarded the Thouron Award to pursue her graduate studies in the United Kingdom. The award was established in 1960 by John Thouron and his wife, Esther du Pont Thouron, to promote closer ties between the U.K. and the United States. The award covers full […]
NIAGADS is pleased to announce the release of whole genome sequencing (WGS) data from 16,906 samples through the Data Sharing Service (DSS). The data release includes CRAMs, gVCFs, and project-level VCFs across all samples. The pVCF released here is provided as a preview to the formal ADSP quality control that will be released in a few months.